August 2019 - 31 articles
In recent years, there has been renewed scientific interest in, and associated media coverage of, psychedelics. [...]
In the context of cancer, adolescents and young adults [...]
Background: Expert groups have recommended incorporation of a geriatric assessment into clinical practice for older patients starting oncologic therapy. However, that practice is not standard primarily because of resource limitations. In the present...
Background: The major limitation in the use of trastuzumab therapy is cardiotoxicity. We evaluated the safety of a strategy of continuing trastuzumab in patients with breast cancer despite mild, asymptomatic left ventricular impairment. Methods: Char...
Background: End-of-life cancer care involves multidisciplinary teams working in various settings. Evaluating the quality of care and the feedback from such processes is an important aspect of health care quality improvement. Our retrospective cohort...
Diffuse large B cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma, accounting for approximately 30% of lymphoma cases in Canada. Although most patients will achieve a cure, up to 40% will experience refractory disease after initial treatmen...
Prescription drug coverage is a significant problem in Canada.[...]
Ten years ago, the Knowledge Translation Research Network (KT-Net) grants program funded its first study in cancer knowledge translation (KT). [...]
Background: A novel way to build capacity in knowledge translation (KT) is through KT-focused grant competitions. Since 2009, the Knowledge Translation Research Network (KT-Net) has had a cancer-related KT grants program. We undertook an evaluation o...
Metronomic chemotherapy (MCTX) encompasses a set of chemotherapy (CTX) doses significantly below the conventional maximum tolerated dose (MTD) and delivered largely continually (without the prolonged drug-free breaks typical of MTD CTX). [...]
of 4
Get Alerted
Add your email address to receive forthcoming issues of this journal.
